Olanzapine

Product NDC
70518-2299
11-digit product format
705182299
Labeler code
70518
Product ID
70518-2299_c7cc1763-7412-f8bb-e053-2a95a90a4e56
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Olanzapine
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA204319
Marketing category
ANDA
Marketing start
2019-09-04
Marketing end
0000-00-00
Substance
OLANZAPINE
Active strength
10 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2299-02023-03-09C16284748780-1f386c64a-078b-0266-e053-dadaa90a7c1a257f93a6-82c3-4d67-b829-930f51a110b1
70518-2299-02023-01-30C16284748780-1f386c64a-078b-0266-e053-dadaa90a7c1a257f93a6-82c3-4d67-b829-930f51a110b1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2299-07051822990030 TABLET in 1 BLISTER PACK (70518-2299-0) 30 tablet2019-09-040000-00-00NoNoCurrent